Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-21-060778

Options or other derivatives

  • General Counsel and Secretary acquired 10,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
KASINGER JAMES R. General Counsel and Secretary 2021-10-15 Grant or award · Stock Option (Right to Buy) +10,800 10,800 D: show line 1 in the form
Loading xslF345X03/doc4.xml…